JBS SCIENCE INC
Doylestown, PA · Medtech · Private
Urine cell-free DNA isolation method and genetic sequencing assay for bladder cancer classification and monitoring
jbs-science.com →- Grants
- $10M
- 15 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $274K
- 1 award · Health and Human S
- #433 of 4531 in medtech
- Patents
- 16
- 4 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Development of a Urine Test for the Early Detection of Liver Cancer | $609,604 | |
| Federal grant | Department of Health and Human Services · Phase I · Development Of A Jbs Hi-lo Urine Dna Kit | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Urine DNA Kit for monitoring HCC recurrence | $300,000 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf Cell-free Circulating Dba-based Assay Development For Liver Cancer Screening | $273,600 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a urine test for the early detection of liver cancer | $1,000,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Development of a JBS HI-LO Urine DNA Kit | $2,000,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Development of a JBS HI-LO Urine DNA Kit | $1,090,481 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a JBS HI-LO Urine DNA Kit | $909,519 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a urine test for the early detection of liver cancer | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of a urine test for the early detection of liver cancer | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel assay to detect integrated HBV DNA in urine of chronic hepatitis B patients | $305,372 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel assay to detect integrated HBV DNA in urine of chronic hepatitis B patients | $298,793 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a PCR assay for quantitative detection of HBV cccDNA | $306,500 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Development of a Urine Genetic Test for NonMuscle Invasive Bladder Cancer | $406,500 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Development of a Urine Genetic Test for NonMuscle Invasive Bladder Cancer | $406,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a PCR assay for quantitative detection of HBV cccDNA | $289,302 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 430 | NEXOGEN INC | $293K | — |
| 431 | MICROBPLEX, INC. | $289K | — |
| 432 | BDYWR, LLC | $275K | — |
| 433 | JBS SCIENCE INC | $274K | — |
| 434 | HYDROCISION INC | $252K | $6.2M |
| 435 | Terapio Corp | $250K | $574K |
| 436 | TYMPANOGEN, INC. | $250K | $2.2M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method And Apparatus For Mixing Megnetic Particles In Liquid Mediumapplication
- Methods For Isolating Circulating Nucleic Acids From Urine Samplesapplication
- Method And Apparatus For Mixing Magnetic Particles In Liquid Mediumapplication
- Method And Kit For Hbv-host Junction Sequence Identification, And Use Thereof In Hepatocellular Carcinoma Characterizationapplication
- CTNNB1 Mutation Detection Kit, Method, And Use In Hcc Detection And Managementapplication
- Kit And Method For Detecting Mutations In CTNNB1 And Htert, And Use Thereof In Hcc Detection And Disease Managementgranted
- Quantitative measurement of Hepatitis B virus cccDNAgranted
- Method For Enrichment And Purification Of Cell-free Dna From Body Fluid For High-throughput Processingapplication
- Detection of hepatitis B virus (HBV) DNA and methylated HBV DNA in urine of patients with HBV-associated hepatocellular carcinomagranted
- Detection of a panel of urine DNA markers for HCC screening and disease managementgranted
- Kit And Method For Detecting Mutations In CTNNB1 And Htert, And Use Thereof In Hcc Detection And Disease Managementapplication
- Method For Enrichment And Purification Of Cell-free Dna From Body Fluid For High-throughput Processingapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.